Clinical trial
Biomarkers For Immune Checkpoint Inhibitors
NCT04204434 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers For Immune Checkpoint Inhibitors
- Lead sponsor
- Rhode Island Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 29, 2016
- Completion date
- April 26, 2024
- Enrollment
- 119 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer, neoplasms